Seongsik Kang Selected Research

Seongsik Kang Research Topics

9	Atrial Fibrillation 01/2022 - 01/2018
5	Stroke (Strokes) 01/2022 - 12/2018
4	Hemorrhage 10/2021 - 08/2019
3	Embolism (Embolus) 10/2021 - 01/2020
2	Thromboembolism 01/2022 - 12/2018
1	Myocardial Infarction 01/2022
1	Peripheral Arterial Disease 01/2022
1	Hyperglycemia 05/2018
1	Ischemic Stroke 01/2018
1	Pain (Aches) 03/2013
1	Drug Overdose 03/2013
1	Hypotension (Low Blood Pressure) 03/2013
1	Respiratory Insufficiency (Respiratory Failure) 03/2013

6	AnticoagulantsIBA 01/2022 - 01/2018
6	Vitamin K FDA Link 01/2022 - 01/2018
4	N(4)-oleylcytosine arabinosideIBA 01/2022 - 01/2018
3	Warfarin (Coumadin)FDA LinkGeneric 01/2022 - 01/2020
1	RivaroxabanIBA 01/2020
1	apixabanIBA 01/2020
1	Dabigatran FDA Link 01/2020
1	Anesthetics (Anesthetic Agents)IBA 05/2018
1	Flumazenil (Romazicon)FDA LinkGeneric 05/2018
1	Midazolam (Versed)FDA LinkGeneric 05/2018
1	BenzodiazepinesIBA 05/2018
1	TransglutaminasesIBA 05/2018
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2018

6	Therapeutics 01/2022 - 03/2013
1	Percutaneous Coronary Intervention 09/2021
1	Intravitreal Injections 05/2018
1	Patient-Controlled Analgesia (Analgesia, Patient Controlled) 03/2013